APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Sarcopenia Healthcare

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sarcopenia Healthcare Market Outlook and Growth Opportunities 2026

Report ID 17403397042 January 2026190 pages

Choose your research edition.

Industry ResearchSarcopenia Healthcare Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Sarcopenia Healthcare Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Sarcopenia Healthcare Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sarcopenia Healthcare Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sarcopenia Healthcare Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Sarcopenia Healthcare market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sarcopenia Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sarcopenia Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sarcopenia Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sarcopenia Healthcare market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sarcopenia Healthcare market include A&Z Pharmaceutical, Abbott Laboratories, Amway, Blackmores, By-health, H&H, Usana, Zhendong Group and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Sarcopenia Healthcare market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sarcopenia Healthcare and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sarcopenia Healthcare revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Sarcopenia Healthcare market.

Sarcopenia Healthcare Segment by Company

A&Z Pharmaceutical

Abbott Laboratories

Amway

Blackmores

By-health

H&H

Usana

Zhendong Group

Bayer

GlaxoSmithKline

Pfizer

Nestlé

Sarcopenia Healthcare Segment by Type

Protein Supplement

Calcium Supplement

Other

Sarcopenia Healthcare Segment by Application

Online Pharmacies

Retail Pharmacies

Sarcopenia Healthcare Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Sarcopenia Healthcare status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Sarcopenia Healthcare key companies, revenue, market share, and recent developments.

3. To split the Sarcopenia Healthcare breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Sarcopenia Healthcare market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sarcopenia Healthcare significant trends, drivers, influence factors in global and regions.

6. To analyze Sarcopenia Healthcare competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sarcopenia Healthcare market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sarcopenia Healthcare and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sarcopenia Healthcare.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sarcopenia Healthcare industry.

Chapter 3: Detailed analysis of Sarcopenia Healthcare company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Sarcopenia Healthcare in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Sarcopenia Healthcare in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sarcopenia Healthcare Industry Trends Table 2. Sarcopenia Healthcare Industry Drivers Table 3. Sarcopenia Healthcare Industry Opportunities and Challenges Table 4. Sarcopenia Healthcare Industry Restraints Table 5. Global Sarcopenia Healthcare Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sarcopenia Healthcare Revenue Share by Company (2021-2026) Table 7. Global Sarcopenia Healthcare Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Sarcopenia Healthcare Key Company Manufacturing Base & Headquarters Table 9. Global Sarcopenia Healthcare Company, Product Type & Application Table 10. Global Sarcopenia Healthcare Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Sarcopenia Healthcare by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Protein Supplement Table 15. Significant Companies of Calcium Supplement Table 16. Significant Companies of Other Table 17. Global Sarcopenia Healthcare Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Sarcopenia Healthcare Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Sarcopenia Healthcare Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Sarcopenia Healthcare Sales Value Share by Type (2021-2026) Table 21. Global Sarcopenia Healthcare Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Online Pharmacies Table 23. Significant Companies of Retail Pharmacies Table 24. Global Sarcopenia Healthcare Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Sarcopenia Healthcare Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Sarcopenia Healthcare Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Sarcopenia Healthcare Sales Value Share by Application (2021-2026) Table 28. Global Sarcopenia Healthcare Sales Value Share by Application (2027-2032) Table 29. Global Sarcopenia Healthcare Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Sarcopenia Healthcare Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Sarcopenia Healthcare Sales Value Share by Region (2021-2026) Table 32. Global Sarcopenia Healthcare Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Sarcopenia Healthcare Sales Value Share by Region (2027-2032) Table 34. Global Sarcopenia Healthcare Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Sarcopenia Healthcare Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Sarcopenia Healthcare Sales Value Market Share by Country (2021-2026) Table 37. Global Sarcopenia Healthcare Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Sarcopenia Healthcare Sales Value Market Share by Country (2027-2032) Table 39. A&Z Pharmaceutical Company Information Table 40. A&Z Pharmaceutical Business Overview Table 41. A&Z Pharmaceutical Sarcopenia Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. A&Z Pharmaceutical Sarcopenia Healthcare Product Portfolio Table 43. A&Z Pharmaceutical Recent Development Table 44. Abbott Laboratories Company Information Table 45. Abbott Laboratories Business Overview Table 46. Abbott Laboratories Sarcopenia Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Abbott Laboratories Sarcopenia Healthcare Product Portfolio Table 48. Abbott Laboratories Recent Development Table 49. Amway Company Information Table 50. Amway Business Overview Table 51. Amway Sarcopenia Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Amway Sarcopenia Healthcare Product Portfolio Table 53. Amway Recent Development Table 54. Blackmores Company Information Table 55. Blackmores Business Overview Table 56. Blackmores Sarcopenia Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Blackmores Sarcopenia Healthcare Product Portfolio Table 58. Blackmores Recent Development Table 59. By-health Company Information Table 60. By-health Business Overview Table 61. By-health Sarcopenia Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. By-health Sarcopenia Healthcare Product Portfolio Table 63. By-health Recent Development Table 64. H&H Company Information Table 65. H&H Business Overview Table 66. H&H Sarcopenia Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. H&H Sarcopenia Healthcare Product Portfolio Table 68. H&H Recent Development Table 69. Usana Company Information Table 70. Usana Business Overview Table 71. Usana Sarcopenia Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Usana Sarcopenia Healthcare Product Portfolio Table 73. Usana Recent Development Table 74. Zhendong Group Company Information Table 75. Zhendong Group Business Overview Table 76. Zhendong Group Sarcopenia Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Zhendong Group Sarcopenia Healthcare Product Portfolio Table 78. Zhendong Group Recent Development Table 79. Bayer Company Information Table 80. Bayer Business Overview Table 81. Bayer Sarcopenia Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Bayer Sarcopenia Healthcare Product Portfolio Table 83. Bayer Recent Development Table 84. GlaxoSmithKline Company Information Table 85. GlaxoSmithKline Business Overview Table 86. GlaxoSmithKline Sarcopenia Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. GlaxoSmithKline Sarcopenia Healthcare Product Portfolio Table 88. GlaxoSmithKline Recent Development Table 89. Pfizer Company Information Table 90. Pfizer Business Overview Table 91. Pfizer Sarcopenia Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Pfizer Sarcopenia Healthcare Product Portfolio Table 93. Pfizer Recent Development Table 94. Nestlé Company Information Table 95. Nestlé Business Overview Table 96. Nestlé Sarcopenia Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Nestlé Sarcopenia Healthcare Product Portfolio Table 98. Nestlé Recent Development Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Sarcopenia Healthcare Product Image Figure 2. Global Sarcopenia Healthcare Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sarcopenia Healthcare Market Size (2021-2032) & (US$ Million) Figure 4. Global Sarcopenia Healthcare Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Protein Supplement Image Figure 8. Calcium Supplement Image Figure 9. Other Image Figure 10. Global Sarcopenia Healthcare Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Sarcopenia Healthcare Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Sarcopenia Healthcare Sales Value Share by Type (2021-2032) Figure 13. Online Pharmacies Image Figure 14. Retail Pharmacies Image Figure 15. Global Sarcopenia Healthcare Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Sarcopenia Healthcare Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Sarcopenia Healthcare Sales Value Share by Application (2021-2032) Figure 18. Global Sarcopenia Healthcare Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Sarcopenia Healthcare Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Sarcopenia Healthcare Sales Value (2021-2032) & (US$ Million) Figure 21. North America Sarcopenia Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Sarcopenia Healthcare Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Sarcopenia Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Sarcopenia Healthcare Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Sarcopenia Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Sarcopenia Healthcare Sales Value (2021-2032) & (US$ Million) Figure 27. South America Sarcopenia Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Sarcopenia Healthcare Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Sarcopenia Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Sarcopenia Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Protein Supplement
  • Calcium Supplement
  • Other
Applications
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • A&Z Pharmaceutical
  • Abbott Laboratories
  • Amway
  • Blackmores
  • By-health
  • H&H
  • Usana
  • Zhendong Group
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Nestlé

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sarcopenia Healthcare Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sarcopenia Healthcare Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Sarcopenia Healthcare Market Dynamics
  1. 2.1 Sarcopenia Healthcare Industry Trends
  2. 2.2 Sarcopenia Healthcare Industry Drivers
  3. 2.3 Sarcopenia Healthcare Industry Opportunities and Challenges
  4. 2.4 Sarcopenia Healthcare Industry Restraints
3 Sarcopenia Healthcare Market by Company
  1. 3.1 Global Sarcopenia Healthcare Company Revenue Ranking in 2025
  2. 3.2 Global Sarcopenia Healthcare Revenue by Company (2021-2026)
  3. 3.3 Global Sarcopenia Healthcare Company Ranking (2024-2026)
  4. 3.4 Global Sarcopenia Healthcare Company Manufacturing Base and Headquarters
  5. 3.5 Global Sarcopenia Healthcare Company Product Type and Application
  6. 3.6 Global Sarcopenia Healthcare Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Sarcopenia Healthcare Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Sarcopenia Healthcare Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Sarcopenia Healthcare Market by Type
  1. 4.1 Sarcopenia Healthcare Type Introduction
  2. 4.1.1 Protein Supplement
  3. 4.1.2 Calcium Supplement
  4. 4.1.3 Other
  5. 4.2 Global Sarcopenia Healthcare Sales Value by Type
  6. 4.2.1 Global Sarcopenia Healthcare Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Sarcopenia Healthcare Sales Value by Type (2021-2032)
  8. 4.2.3 Global Sarcopenia Healthcare Sales Value Share by Type (2021-2032)
5 Sarcopenia Healthcare Market by Application
  1. 5.1 Sarcopenia Healthcare Application Introduction
  2. 5.1.1 Online Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.2 Global Sarcopenia Healthcare Sales Value by Application
  5. 5.2.1 Global Sarcopenia Healthcare Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Sarcopenia Healthcare Sales Value by Application (2021-2032)
  7. 5.2.3 Global Sarcopenia Healthcare Sales Value Share by Application (2021-2032)
6 Sarcopenia Healthcare Regional Value Analysis
  1. 6.1 Global Sarcopenia Healthcare Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sarcopenia Healthcare Sales Value by Region (2021-2032)
  3. 6.2.1 Global Sarcopenia Healthcare Sales Value by Region: 2021-2026
  4. 6.2.2 Global Sarcopenia Healthcare Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sarcopenia Healthcare Sales Value (2021-2032)
  7. 6.3.2 North America Sarcopenia Healthcare Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Sarcopenia Healthcare Sales Value (2021-2032)
  10. 6.4.2 Europe Sarcopenia Healthcare Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Sarcopenia Healthcare Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Sarcopenia Healthcare Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Sarcopenia Healthcare Sales Value (2021-2032)
  16. 6.6.2 South America Sarcopenia Healthcare Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Sarcopenia Healthcare Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Sarcopenia Healthcare Sales Value Share by Country, 2025 VS 2032
7 Sarcopenia Healthcare Country-level Value Analysis
  1. 7.1 Global Sarcopenia Healthcare Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sarcopenia Healthcare Sales Value by Country (2021-2032)
  3. 7.2.1 Global Sarcopenia Healthcare Sales Value by Country (2021-2026)
  4. 7.2.2 Global Sarcopenia Healthcare Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Sarcopenia Healthcare Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Sarcopenia Healthcare Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Sarcopenia Healthcare Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 A&Z Pharmaceutical
  2. 8.1.1 A&Z Pharmaceutical Company Information
  3. 8.1.2 A&Z Pharmaceutical Business Overview
  4. 8.1.3 A&Z Pharmaceutical Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  5. 8.1.4 A&Z Pharmaceutical Sarcopenia Healthcare Product Portfolio
  6. 8.1.5 A&Z Pharmaceutical Recent Developments
  7. 8.2 Abbott Laboratories
  8. 8.2.1 Abbott Laboratories Company Information
  9. 8.2.2 Abbott Laboratories Business Overview
  10. 8.2.3 Abbott Laboratories Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Abbott Laboratories Sarcopenia Healthcare Product Portfolio
  12. 8.2.5 Abbott Laboratories Recent Developments
  13. 8.3 Amway
  14. 8.3.1 Amway Company Information
  15. 8.3.2 Amway Business Overview
  16. 8.3.3 Amway Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Amway Sarcopenia Healthcare Product Portfolio
  18. 8.3.5 Amway Recent Developments
  19. 8.4 Blackmores
  20. 8.4.1 Blackmores Company Information
  21. 8.4.2 Blackmores Business Overview
  22. 8.4.3 Blackmores Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Blackmores Sarcopenia Healthcare Product Portfolio
  24. 8.4.5 Blackmores Recent Developments
  25. 8.5 By-health
  26. 8.5.1 By-health Company Information
  27. 8.5.2 By-health Business Overview
  28. 8.5.3 By-health Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  29. 8.5.4 By-health Sarcopenia Healthcare Product Portfolio
  30. 8.5.5 By-health Recent Developments
  31. 8.6 H&H
  32. 8.6.1 H&H Company Information
  33. 8.6.2 H&H Business Overview
  34. 8.6.3 H&H Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  35. 8.6.4 H&H Sarcopenia Healthcare Product Portfolio
  36. 8.6.5 H&H Recent Developments
  37. 8.7 Usana
  38. 8.7.1 Usana Company Information
  39. 8.7.2 Usana Business Overview
  40. 8.7.3 Usana Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Usana Sarcopenia Healthcare Product Portfolio
  42. 8.7.5 Usana Recent Developments
  43. 8.8 Zhendong Group
  44. 8.8.1 Zhendong Group Company Information
  45. 8.8.2 Zhendong Group Business Overview
  46. 8.8.3 Zhendong Group Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Zhendong Group Sarcopenia Healthcare Product Portfolio
  48. 8.8.5 Zhendong Group Recent Developments
  49. 8.9 Bayer
  50. 8.9.1 Bayer Company Information
  51. 8.9.2 Bayer Business Overview
  52. 8.9.3 Bayer Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bayer Sarcopenia Healthcare Product Portfolio
  54. 8.9.5 Bayer Recent Developments
  55. 8.10 GlaxoSmithKline
  56. 8.10.1 GlaxoSmithKline Company Information
  57. 8.10.2 GlaxoSmithKline Business Overview
  58. 8.10.3 GlaxoSmithKline Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GlaxoSmithKline Sarcopenia Healthcare Product Portfolio
  60. 8.10.5 GlaxoSmithKline Recent Developments
  61. 8.11 Pfizer
  62. 8.11.1 Pfizer Company Information
  63. 8.11.2 Pfizer Business Overview
  64. 8.11.3 Pfizer Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pfizer Sarcopenia Healthcare Product Portfolio
  66. 8.11.5 Pfizer Recent Developments
  67. 8.12 Nestlé
  68. 8.12.1 Nestlé Company Information
  69. 8.12.2 Nestlé Business Overview
  70. 8.12.3 Nestlé Sarcopenia Healthcare Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Nestlé Sarcopenia Healthcare Product Portfolio
  72. 8.12.5 Nestlé Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst